Coronary Artery Calcium Analysis and Reporting on Noncontrast Chest CT Scans: a Paradigm Shift in Prevention
Tóm tắt
The quantification of coronary artery calcium (CAC) on gated noncontrast cardiac CT, as a screening test for subclinical coronary artery disease, has been consistently proven to be superior to risk factors and biomarkers for the prediction of long-term cardiovascular risk. Coronary artery calcium is also readily evaluable in every noncontrast (nongated) chest CT scan, yet there are no recommendations for reporting CAC in scans done for noncardiac indications. Lung CT scanning has been approved for lung cancer screening, and almost all the candidates are intermediate to high risk for coronary artery disease, which can be powerfully evaluated by the assessment of CAC at no additional radiation or cost. There are technical requirements for scanner detectors, slice thickness, and voltage which are easily satisfied. EKG gating provides the highest quality studies but will be more difficult to universally implement. Agatston scoring, ordinal scoring, and visual estimation of nongated scans offer alternatives and are supported by varying degrees of data. Similarly, newer reconstruction algorithms are available but are not yet widely used. Barriers to reporting include increased time and lack of increased reimbursement for CAC analysis, difficulties inherent to reporting abnormal results, and referring physician understanding and utilization of the results to alter patient education and management.
Tài liệu tham khảo
Berrington de Gonzalez A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med [Research Support, Non-US Gov’t. 2009;169(22):2071–7.
Moyer VA, on behalf of the U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:330–8.
National Coverage Analysis (NCA) for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). Available at: http://www.cms.gov/medicare-coverage-database/details/nce-details.aspx?NCAld=272&NcaName+Screening+for+Lung+Cancer+with+Low+Does+Computed+Tomography+(LDCT)&MEDCACld=68&IsPopup=y&.
Polonsky TS, Greenland P. Coronary artery calcium scores using nongated computed tomography. What to do with incidental results? Circ Cardiovasc Imaging. 2013;6:494–95. Well-reasoned editorial on the importance of reporting coronary calcium on CT scans.
ACR–SCBT-MR–SPR practice parameter for the performance of thoracic computed tomography (CT) Res. 10 – 2013, Amended 2014 (Res. 39).
International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763–71.
National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. New Engl J Med. 2011;365:395–409.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: lung cancer screening. Version 1, 2013. http://www.respiratory-thessaly.gr/assets/lung_screening%201.2013.pdf. Formal recognition of CT as a screening tool for lung cancer
Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts WM. Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5_suppl):7S–37S.
Wender R, Fontham ETH, Barrera E. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63:107–17.
Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144:33–8.
American Lung Association. Providing guidance on lung cancer screening to patients and physicians. April 23, 2012. http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/lung-cancer-screening.pdf.
Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.
Perk J, De Backer G, Gohlke H, et al. ESC Committee for Practice Guidelines (CPG) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J. 2012;33:1635–701.
Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol. 2013. doi:10.1016/j.jacc.2013.11.002.
Greenland P, Alpert JS, Beller GA, American College of Cardiology Foundation; American Heart Association. 2010 ACCF ⁄ AHA guideline for assessment of cardiovascular risk in adults: a report of the American College of Cardiology Foundation ⁄ American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2010;56:e50–103. First and most evidence based guideline to strongly recommend CAC scanning.
Taylor AJ, Cerqueira M, Hodgson JM. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. J Am Coll Cardiol. 2010;56:1864–94.
Goff Jr DC, Lloyd-Jones DM, Bennett G. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol. 2014. doi:10.1016/j.jacc.2013.11.005.
Nair A, Hansell DM. European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol. 2011;21(12):2445–54.
Field JK, van Klaveren R, Pedersen JH, European Randomized Screening Trial Group, et al. European randomized lung cancer screening trials: post NLST. J Surg Oncol. 2013;108:280–6.
Hecht HS, de Siqueira MEM, Cham M, et al. Low versus standard dose coronary artery calcium scanning. Eur Heart J Cardiovasc Imaging. 2015;16:358–63. Documents the feasibility of CAC scanning at very low radiation doses.
Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Matthew J, et al. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185:394–9.
Williams KA, Kim JT, Holohan KM. Frequency of unrecognized, unreported, or underreported coronary artery and cardiovascular calcification on noncardiac chest CT. J Cardiovasc Com Tom. 2013;7:167–72. Documents underreporting of coronary calcium on CT scans.
Uretsky S, Chokshi N, Kobrinski T, et al. The interplay of physician awareness and reporting of incidentally found coronary artery calcium on the clinical management of patients who underwent noncontrast chest computed tomography. Am J Cardiol. 2015;115:1513–7.
Hecht HS. Coronary artery calcium scanning: past, present and future. J Am Coll Cardiol Img. 2015;8:579–96. State-of-the-art review of all aspects of coronary calcium scanning.
Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610–6.
Erbel R, Möhlenkamp S, Moebus S, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis. The Heinz Nixdorf Recall Study. J Am Coll Cardiol. 2010;56:1397–406.
Elias-Smale SE, Proença RV, Koller MT. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol. 2010;56:1407–14.
Orakzai RH, Nasir K, Orakzai SH, et al. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol. 2008;101:999–1002.
Taylor AJ, Bindeman J, Feuerstein I, et al. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. J Am Coll Cardiol. 2008;51:1337–41.
Rozanski A, Gransar H, Shaw LJ, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: the EISNER (Early Identification of Subclinical Athero, sclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol. 2011;57:1622–32. Illustrates impact of coronary calcium on risk factors and testing.
Brugts JJ, Yetgin T, Hoeks SE. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ. 2009;338:b2376.
De Koning HJ, Van Der Aalst CM, Van Aerde MA, Ijkema R, Van Bruggen R, Oudkerk M. Design and recruitment of the ROBINSCA trial: screening for cardiovascular disease. Euro Heart J. 2015;36:S985. Ongoing randomized trial on the effect of coronary calcium on clinical outcomes.
American Association of Physicists in medicine position statement on radiation risks from medical imaging procedures. 2011; 25-A. http://federalregister.gov/a/2015-28005
Picano E, Vano E, Rehan MM. The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and Electrophysiology. Euro Heart J. 2014. doi:10.1093/eurheartj/eht394.
Larke FJ, Kruger RL, Cagnon CH, et al. Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial. Am J Roentgenol. 2011;197:1165–9.
Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–83.
Willemink MJ, Borstlap J, Takx RAP, et al. The effects of computed tomography with iterative reconstruction on solid pulmonary nodule volume quantification. PLoS One. 2013;8(2):e58053. doi:10.1371/journal.pone.005803.
Chen B, Barnhart H, Richard S, Robins M, Colsher J, Samei E. Volumetric quantification of lung nodules in CT with iterative reconstruction (ASiR and MBIR). Med Phys. 2013;40(11):111902. doi:10.1118/1.4823463.
Black WC, Gareen IF, Soneji SS, et al. Cost effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med. 2014;371:1793–82.
van Kempen BJH, Spronk S, Koller, et al. Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals. J Am Coll Cardiol. 2011;58:1690–71.
Pletcher MJ, Pignone M, Earnshaw S, et al. Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2014;7:276–84. Convincing demonstration of coronary calcium cost-effectiveness.
Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 2006;114:1761–91.
Kim SM, Chung MJ, Lee KS, Choe YH, Yi CA, Choe BK. Coronary calcium screening using low-dose lung cancer screening: effectiveness of MDCT with retrospective reconstruction. Am J Roentgenol. 2008;190:917–22.
Wu MT, Yang P, Huang YL, et al. Coronary arterial calcification on low-dose ungated MDCT for lung cancer screening: concordance study with dedicated cardiac CT. Am J Roentgenol. 2008;190:923–8.
Budoff MJ, Nasir K, Kinney GL, et al. Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD gene cohort. J Cardiovasc Comput Tomogr. 2011;5:113–8.
Xie X, Zhao Y, de Bock GH, et al. Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography systematic review and meta-analysis. Circ Cardiovasc Imaging. 2013;6:514–21.
Hughes-Austin JM, Dominguez A, Allison MA, et al. Relationship of coronary artery calcium on standard chest computed tomography scans with mortality. J Am Coll Cardiol Img. 2016;9:152–9. doi:10.1016/j.jcmg.2015.06.030
Takx RAP, de Jong PA, Leiner T, et al. Automated coronary artery calcification scoring in non-gated chest CT: agreement and reliability. PLoS One. 2014;9(3):e91239. doi:10.1371/journal.pone.0091239.
Jacobs PC, Prokop M, van der Graaf Y, et al. Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. Atherosclerosis. 2010;209:455–62.
Mets OM, Vliegenthart R, Gondrie MJ, et al. Lung cancer screening CT-based prediction of cardiovascular events. J Am Coll Cardiol Img. 2013;6:899–907.
Chiles C, Duan F, Gladish GW, et al. Association of coronary artery calcification and mortality in the National Lung Screening Trial: a comparison of three scoring methods. Radiology. 2015;76:82–90. Effects of 3 different calcium scoring methods on outcomes.
Shemesh J, Henschke CI, Shaham D, et al. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest predicts deaths from cardiovascular disease. Radiology. 2010;257:541–8.
Htwe Y, Cham M, Claudia Henschke C, et al. Coronary artery calcification on low-dose non gated computed tomography: comparison of Agatston and ordinal scores. Clin Imaging. 2015;39:799–802.
Hecht HS, Henschke CI, Yankelevitz D, Fuster V, Narula J. Combined detection of coronary artery disease and lung cancer. Eur Heart J. 2014;35:2792–6.